Hints might be derived from prostate cancer, since in the prostate a dysregulated cellular growth is mediated by inhibiting the rate-limiting pathway step in cholesterol synthesis, thereby decreasing isoprenylate intermediates, decreasing cholesterol rich cellular membrane domains, and down-regulating androgen and estrogen receptors [32]. This evidence concerns the gene ESR1 and Familial prostate cancer.